Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-26
DOI
10.1038/s41598-021-81538-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
- (2020) Jinli Wei et al. BREAST
- Lymph node positivity in different early breast carcinoma phenotypes: a predictive model
- (2019) Gilles Houvenaeghel et al. BMC CANCER
- Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
- (2018) Galina Velikova et al. LANCET ONCOLOGY
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative
- (2017) Ning Liu et al. Oncotarget
- Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer
- (2016) Lars Jønson et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
- (2015) Jonas Vikeså et al. BMC CANCER
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Breast cancer subtypes can be determinant in the decision making process to avoid surgical axillary staging: A retrospective cohort study
- (2015) Antonio Marrazzo et al. International Journal of Surgery
- A Predictive Tool to Estimate the Risk of Axillary Metastases in Breast Cancer Patients with Negative Axillary Ultrasound
- (2014) T. J. Meretoja et al. ANNALS OF SURGICAL ONCOLOGY
- Reduced risk of axillary lymphatic spread in triple-negative breast cancer
- (2014) Emil Villiam Holm-Rasmussen et al. BREAST CANCER RESEARCH AND TREATMENT
- Implementation of TMA and digitalization in routine diagnostics of breast pathology
- (2012) Henrik Holm Rossing et al. APMIS
- The sva package for removing batch effects and other unwanted variation in high-throughput experiments
- (2012) Jeffrey T. Leek et al. BIOINFORMATICS
- PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
- (2012) A. Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma
- (2012) C. Ngô et al. EJSO
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- A Simple Nomogram to Evaluate the Risk of Nonsentinel Node Metastases in Breast Cancer Patients with Minimal Sentinel Node Involvement
- (2011) T. J. Meretoja et al. ANNALS OF SURGICAL ONCOLOGY
- A refined molecular taxonomy of breast cancer
- (2011) M Guedj et al. ONCOGENE
- The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
- (2011) Fabien Reyal et al. PLoS One
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
- (2010) David N Krag et al. LANCET ONCOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pathway-based classification of human breast cancer
- (2010) M. L. Gatza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
- (2008) Ben Van Calster et al. BREAST CANCER RESEARCH AND TREATMENT
- Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer
- (2008) Simon J. Crabb et al. Clinical Breast Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started